85-year-old patient with ischemic heart disease, who underwent cardiac MRI at 3 T

85-year-old patient with ischemic heart disease, who underwent cardiac MRI at 3 T.

A. Short-axis image from standard cine balanced SSFP breath-hold sequence.

B. Short-axis image from free-breathing accelerated cine sequence with deep-learning reconstruction. Images show normal appearance of left ventricular myocardium


February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may yield reliable left ventricular ejection fraction (LVEF) measurements in patients with ischemic heart disease (IHD) unable to repeatedly breath-hold.

“Free-breathing cine-DL sequence, in comparison with standard breath-hold cine sequence, showed very small bias for LVEF measurements and better subjective quality,” wrote David Monteuuis, MD, from the department of radiology at Amiens University Hospital in France. “Cine-DL yielded greater left ventricular volumes.”

David et al.’s AJR accepted manuscript included patients undergoing 1.5-T or 3-T cardiac MRI for evaluation of IHD (March 15–June 21, 2023). Examinations included an investigational free-breathing cine short-axis sequence with DL reconstruction (cine-DL). In blinded fashion, two radiologists (R1, R2) independently assessed LVEF, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and subjective image quality, for cine-DL sequence and standard breath-hold balanced SSFP sequences; R1 assessed artifacts.

Ultimately, in patients with IHD, the free-breathing cine sequence with DL reconstruction showed very low bias for LVEF measurements (R1: 0.4%; R2: 0.7%) and better subjective image quality (R1: 2.3±0.5 vs 1.9±0.8; R2: 2.2±0.4 vs 1.9±0.7) in shorter acquisition times (0.6±0.1 vs 2.4±0.6 min).

“This free-breathing cine-DL sequence could be particularly useful in the evaluation of patients with dyspnea who are unable to perform repeated breath-holds,” the AJR authors added.

For more information: www.arrs.or


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Feature | SCCT | by Christine Book

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

Time June 27, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
Subscribe Now